Abstract PS18-07: Differential odds of response in ILC versus IDC correlate with changes in the TIME in a phase II trial of pre-operative fulvestrant with or without enzalutamideJennifer K. Richer, Dexiang Gao, Alyse Staley et al.|Clinical Cancer Research|2025Cited by 0